Long-Acting Reversible Contraceptive (LARC) methods are a great option for people who want a method they don’t have to think about. This Contraceptive Pearl addresses LARC use, specifically for teens.
The Zika virus poses an international public health threat. A more vigorous and appropriate response to Zika should include full access to contraception, prenatal care, options counseling, abortion care, and pediatric developmental services. Read about the relation between the Zika virus and reproductive health in this Contraceptive Pearl.
Which oral contraceptive pills (OCPs) are best for patients at risk for cardiovascular disease? Find out in this Contraceptive Pearl.
The progestin IUD is a safe and effective method of decreasing menstrual bleeding which spares future fertility and decreases costs.
Implant removal can be significantly more difficult than insertion. This Contraceptive Pearl details the “pop-out” or “fingers only” implant removal technique, which requires less anesthesia and a smaller incision and causes less swelling than removal with instruments.
This Contraceptive Pearl covers Depo SubQ, the version of depot medroxyprogesterone acetate (DMPA) that can be prescribed as a subcutaneous injection that patients give themselves at home. It contains about 30% less progestin than the in-office form, which may reduce some of Depo’s side effects.
People with physical disabilities often lack basic reproductive health care. This Contraceptive Pearl describes how providers can go beyond compliance with the Americans with Disabilities Act towards full accessibility for patients with impaired mobility.
In this Contraceptive Pearl, options of contraception for women who have experienced abnormal pap smears are detailed.
For many years, clinicians and patients were concerned that hormonal contraceptives might raise the risk of developing breast cancer. Fortunately, studies indicate that using hormonal contraception does not contribute to breast cancer. This Contraceptive Pearl details the history and relationship between hormonal contraceptives and breast cancer.
A new “one size fits most” diaphragm, Caya, was approved by the FDA in September 2014 and is now available in the US. Find out about the new diaphragm in this Contraceptive Pearl.
Your gift allows us to mobilize, train, and support clinicians across the country to provide reproductive health care.